CFGS
OYST

Concourse Financial Group Securities’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Concourse Financial Group Securities’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,800
Closed -$81K – 2501
2021
Q4 		$124K Hold
6,800
– – 0.01% 910
2021
Q3 		$81K Hold
6,800
– – ﹤0.01% 1096
2021
Q2 		$117K Sell
6,800
-500
-7% -$9.5K 0.01% 925
2021
Q1 		$133K Hold
7,300
– – 0.01% 823
2020
Q4 		$137K Buy
7,300
+200
+3% +$4.31K 0.01% 770
2020
Q3 		$150K Buy
+7,100
New +$166K 0.01% 640

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Concourse Financial Group Securities's OYST Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 6,800 shares — an estimated $81K sold.

Concourse Financial Group Securities first reported a position in OYST in Q3 2020 and held it in 6 quarters. The position peaked at $150K in Q3 2020. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

  • Concourse Financial Group Securities reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 6,800 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $81K.
  • Concourse Financial Group Securities first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Concourse Financial Group Securities's Oyster Point Pharma, Inc. Common Stock position peaked at $150K in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.